ArticleJournal of asthma and allergy2026

Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study.

Muhammad Adrish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.